Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes (Q33585686)

28 July 2017

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes (English)

1 reference

28 July 2017

0 references

Daisuke Yabe

1

0 references

Nobuya Inagaki

object named as

Nobuya Inagaki

15

0 references

author name string

Koin Watanabe

2

1 reference

28 July 2017

Kenji Sugawara

3

1 reference

28 July 2017

Hitoshi Kuwata

4

1 reference

28 July 2017

Yuka Kitamoto

5

1 reference

28 July 2017

Kazu Sugizaki

6

1 reference

28 July 2017

Shuichi Fujiwara

7

1 reference

28 July 2017

Masahiro Hishizawa

8

1 reference

28 July 2017

Takanori Hyo

9

1 reference

28 July 2017

Kyoko Kuwabara

10

1 reference

28 July 2017

Kayo Yokota

11

1 reference

28 July 2017

Masahiro Iwasaki

12

1 reference

28 July 2017

Naomi Kitatani

13

1 reference

28 July 2017

Takeshi Kurose

14

1 reference

28 July 2017

Yutaka Seino

16

1 reference

28 July 2017

1 February 2012

1 reference

Journal of Diabetes Investigation

28 July 2017

1 reference

28 July 2017

3

1 reference

28 July 2017

1

1 reference

28 July 2017

70-79

1 reference

Report of the committee on the classification and diagnostic criteria of diabetes mellitus

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

GIP and GLP-1, the two incretin hormones: Similarities and differences

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Molecular mechanisms underlying nutrient-stimulated incretin secretion

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Immunoassays for the incretin hormones GIP and GLP-1.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Glucose sensing in L cells: a primary cell study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

The Physiology of Glucagon-like Peptide 1

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

The biology of incretin hormones

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Hypersecretion of gastric inhibitory polypeptide induced by glucose ingestion in diabetes mellitus.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Somatostatin-like Immunoreactivity in Human Peripheral Plasma Measured by Radioimmunoassay Following Affinity Chromatography

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Hypersecretion of Gastric Inhibitory Polypeptide Following Oral Glucose in Diabetes Mellitus

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus

14 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

Non-linear increase in GLP-1 levels in response to DPP-IV inhibition in healthy adult subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014935

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus

31 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2011.00141.X

The nature of big plasma somatostatin: implications for the measurement of somatostatin-like immunoreactivity in human plasma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24843548

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24843548

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.2040-1124.2011.00141.X

1 reference

28 July 2017

1 reference

28 July 2017

1 reference